Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
retina
Biotech
Regeneron snaps up eye biotech, snaring science but not staff
No Oxular employees are joining Regeneron, though several will help "short-term with tech transfer and transition work,” a spokesperson said.
Gabrielle Masson
Jan 2, 2025 3:58pm
Atsena downsizes to funnel money toward new capsid program
Oct 5, 2023 1:47pm
Zeiss, Boehringer eye retinal disease-focused predictive AI pact
Oct 2, 2023 1:00pm
Cash-strapped eye disease biotech halves portfolio
Aug 8, 2023 2:36pm
Vedere Bio II, unimpressed by preclinical work, shuts down
Apr 3, 2023 10:35am
Quick retina scans may be AI's key to predicting heart disease
Oct 7, 2022 11:41am
